ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering
ADARx Pharmaceuticals has priced its upsized initial public offering of 26.25 million shares at $17.00 per share, expecting to raise approximately $446.3 million in gross proceeds. The shares will begin trading on the Nasdaq Global Select Market under the ticker 'ADRX'. Concurrently, AbbVie has agreed to purchase up to $100 million of common stock …